top of page

Investor Relation

FILINGS AND DISCLOSURE

OTC Disclosure & News

PUBLISH DATE
TITLE
PERIOD END DATE
STATUS
25/01/2023
OTCQB Certification - OTCQB Certification
31/12/2021
A
01/04/2022
OTCQB Certification - OTCQB Certification
31/12/2021
A
29/04/2021
OTCQB Certification - OTCQB Certification
31/12/2020
A
01/04/2021
Annual Report - Annual Report
31/12/2020
A
09/07/2020
OTCQB Certification - OTCQB Certification
31/12/2019
A
03/07/2020
OTCQB Certification - OTCQB Certification
31/12/2019
A
03/07/2020
OTCQB Certification - OTCQB Certification
31/12/2019
A

SEC Filings

FORM TYPE
RECEIVED
PERIOD END DATE
HTML
XLS
DEF 14C
17/05/2023
16/05/2023
HTML
XLS
10-Q
09/05/2023
31/03/2023
HTML
XLS
S-1/A
09/05/2023
HTML
XLS
10-K
31/03/2023
31/12/2022
HTML
XLS
DEFR14C
10/03/2023
HTML
XLS
DEF 14C
21/02/2023
21/02/2023
HTML
XLS
S-1
14/02/2023
HTML
XLS
PRE 14C
10/02/2023
10/02/2023
HTML
XLS
10-Q
14/11/2022
30/09/2022
HTML
XLS
10-Q
15/08/2022
30/06/2022
HTML
XLS
Page 1 of 4

INSIDER DISCLOSURE

Disclosure & News

Code of Ethics and Business Conduct

We have adopted a code of ethics and business conduct applicable to our directors, officers and employees. This includes our principal executive officer, principal financial officer and principal accounting officer or controller, or persons performing similar functions.

Click the pages below or click here for the details.

For further information on investor relation, please email to ir@bionexuslab.com

bottom of page